Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2606-2610

  Haddad, Lema ^a   Evans, Julie C ^b   Gharani, Neda ^c   Robertson, Carole ^d   Rush, Karen ^e   Wiltshire, Steven ^f   Frayling, Timothy M ^g   Wilkin, Terence J ^g   Demaine, Andrew ^h   Millward, Ann ^a   Hattersley, Andrew T ^c   Conway, Gerry ^f   Cox, Nancy J ^g   Bell, Graeme I ^g   Franks, Steve ^h   McCarthy, Mark I ^a,h  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^f MIDDLESEX HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CHICAGO   (United States)

^h IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAPN10 GENE; CHROMOSOME 2Q; EPIDEMIOLOGICAL DATA; ETHNIC GROUP; EUROPE; FEMALE; GENE ISOLATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

FALLOPIA;

EID: 18444367986     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8608     Document Type: Article

References (44)

1. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
2. Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies
3. Selective insulin resistance in the polycystic ovary syndrome
4. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome
5. Defects in insulin secretion and action in women with a history of gestational diabetes
6. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
7. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
8. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus
9. The prevalence of polycystic ovaries in women with a history of gestational diabetes
10. Polycystic ovary syndrome: A changing perspective
11. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
12. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome
13. Human type 1 diabetes and the insulin gene: Principles of mapping polygenes
14. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles
15. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2
16. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans
17. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
18. Guilt by association
19. Genetic variation at the calpain 10 gene is associated with insulin resistance and type 2 diabetes in Finland
20. Genetic variation of CAPN10 affects susceptibility to type 2 diabetes in German and Czech population
21. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom
22. The impact of calpain 10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits
23. Association of calpain 10 genetic polymorphisms with type 2 diabetes and insulin response in non-diabetic Chinese
24. Type 2 diabetes and three Calpain-10 gene polymorphisms in Samoans: No evidence of association
25. Allelic variations in calpain 10, PPARγ genes and risk of type 2 diabetes in a Polish population
26. Calpain: New perspectives in molecular diversity and physiological-pathological involvement
27. Calpain: A protease in search of a function?
28. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
29. Rapid, specific and sensitive enzyme-linked immunosorbent assay for intact human insulin
30. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome
31. Comparison of six commercial DNA extraction kits for recovery of cytomegalovirus DNA from spiked human specimens
32. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
33. Electrophoresis for genotyping: Microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose
34. The TDT and other family based tests for linkage disequilibrium and association
35. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission
36. Transmission/disequilibrium tests for extended marker haplotypes
37. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
38. Calpain inhibitors impair insulin secretion after 48-hours: A model for β-cell dysfunction in type 2 diabetes?
39. Calpain-sensitive pathways in insulin secretion and action - A pathophysiological basis for type 2 diabetes?
40. Reduced skeletal muscle calpain-10 transcript level is due to cumulative decrease in major isoforms
41. Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in non-diabetic humans
42. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
43. Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: Examples from studies of the calpain 10 gene
44. Association study designs for complex diseases